Goldman Sachs Downgrades Healthways Inc. (HWAY) to Sell
More News related to HWAY
- Healthways to Present at the Credit Suisse 18th Annual Healthcare Conference
- Stifel Nicolaus Downgrades Healthways (HWAY) to Hold
- Jefferies & Co Upgrades Healthways (HWAY) to Buy
- Morning Movers 10/23: AMZN, CPWR, EPAY, ALGN, HWAY, SCSS, ACO Higher; ELN, SNV, CBRX, RMTR, STSA, DVAX Lower
- Piper Jaffray Upgrades Healthways (HWAY) to Neutral; Strong Execution in Tough Environment
More News related to Downgrades
- After-Hours Movers 11/09: SGK, PCLN, SQNM Higher; MBI, SDTH, UTK, TOPS, CPST, BTN, FLR Lower
- Trading Radar for 11/10: Tyco Int. (TYC), ArvinMeritor (ARM), Clearwire (CLWR), American Apparel (APP) Report
- Unusual 11 Mid-Day Movers 11/09: EONC, EWBC, REV, PRST Higher; GTN, CHNG, SRZ, CHDX Lower
- Notable Analyst Rating Changes: RSH, ANF, NOC, ADBE, HERO Upgraded; RIMM, RHT, GPS, AZN, SGY Downgraded
- Morning Movers 11/09: EWBC, CVM, REV, CGEN, RSH Higher; CHDX, SRZ, GTN, RPRX, VSR Lower
Goldman Sachs downgrades Healthways Inc. (Nasdaq: HWAY) from Neutral to Sell but raises their price target from $9 to $10, which still suggest 31% downside to the current market price.
The firm cites several challenges including in-sourcing risk from national health plan clients and pricing pressure due to the economy among other things.
Healthways, Inc. provides specialized Health and Care Support solutions.
Real-Time Market Moving News Two-Weeks FREE http://www.streetinsider.com/premium_content.php
Related Categories
DowngradesTrader Talk
Stocks Mentioned
-0.07Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
